NO20092763L - Isosorbid mononitrat derivater for behandling av tarmlidelser - Google Patents

Isosorbid mononitrat derivater for behandling av tarmlidelser

Info

Publication number
NO20092763L
NO20092763L NO20092763A NO20092763A NO20092763L NO 20092763 L NO20092763 L NO 20092763L NO 20092763 A NO20092763 A NO 20092763A NO 20092763 A NO20092763 A NO 20092763A NO 20092763 L NO20092763 L NO 20092763L
Authority
NO
Norway
Prior art keywords
treatment
intestinal disorders
isosorbide mononitrate
mononitrate derivatives
derivatives
Prior art date
Application number
NO20092763A
Other languages
English (en)
Norwegian (no)
Inventor
Jose Repolles Moliner
Francisco Pubill Coy
Marisabel Mourelle Mancini
Original Assignee
L Cer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38043051&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20092763(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by L Cer Sa filed Critical L Cer Sa
Publication of NO20092763L publication Critical patent/NO20092763L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20092763A 2006-12-28 2009-07-27 Isosorbid mononitrat derivater for behandling av tarmlidelser NO20092763L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06380338A EP1941876A1 (en) 2006-12-28 2006-12-28 Isosorbide mononitrate derivatives for the treatment of Inflammation and ocular hypertension
PCT/EP2007/064591 WO2008080955A1 (en) 2006-12-28 2007-12-27 Isosorbide mononitrate derivatives for the treatment of intestinal disorders

Publications (1)

Publication Number Publication Date
NO20092763L true NO20092763L (no) 2009-07-27

Family

ID=38043051

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20092763A NO20092763L (no) 2006-12-28 2009-07-27 Isosorbid mononitrat derivater for behandling av tarmlidelser
NO20092764A NO20092764L (no) 2006-12-28 2009-07-27 Isosorbid mononitrat derivater for behandling av okular hypertensjon

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20092764A NO20092764L (no) 2006-12-28 2009-07-27 Isosorbid mononitrat derivater for behandling av okular hypertensjon

Country Status (21)

Country Link
US (1) US20080161389A1 (es)
EP (3) EP1941876A1 (es)
JP (2) JP2010514734A (es)
KR (2) KR20100100584A (es)
CN (2) CN101600425A (es)
AR (1) AR064543A1 (es)
AT (2) ATE472324T1 (es)
AU (2) AU2007341218B2 (es)
BR (2) BRPI0720664A2 (es)
CA (2) CA2674144A1 (es)
CL (2) CL2007003837A1 (es)
DE (2) DE602007007523D1 (es)
ES (3) ES2324130B1 (es)
IL (2) IL198912A0 (es)
MX (2) MX2009007038A (es)
NO (2) NO20092763L (es)
PL (2) PL2114398T3 (es)
RU (2) RU2009128968A (es)
UY (1) UY30847A1 (es)
WO (2) WO2008080939A1 (es)
ZA (2) ZA200903567B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2149576A1 (en) * 2008-07-22 2010-02-03 Lacer, S.A. Isosorbide Nitrates having vasodilating activity
EP2149577B1 (en) * 2008-07-22 2011-04-27 Lacer, S.A. New stereospecific method for the preparation of dioxa-bicyclooctane compounds
EP2177216A1 (en) * 2008-10-13 2010-04-21 Lacer, S.A. Use of dianhydrohexite mononitrate derivatives as healing agents
WO2010055138A1 (en) * 2008-11-14 2010-05-20 Lacer, S.A. New stereospecific method for the preparation of dioxa-bicyclooctane compounds
EP2199294A1 (en) * 2008-12-19 2010-06-23 Lacer, S.A. New stereospecific method for the preparation of dioxa bicyclooctane nitrate compounds
EP2515899B1 (en) * 2009-12-23 2016-05-25 ARCA biopharma, Inc. Methods and compositions for cardiovascular diseases and conditions
US20160016969A1 (en) * 2013-03-05 2016-01-21 Archer Daniels Midland Company Isohexide monotriflates and process for synthesis thereof
WO2018224419A1 (en) 2017-06-06 2018-12-13 Nicox S.A. Nitric oxide donating isomannide derivatives

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2739689C2 (de) * 1977-09-02 1986-10-16 Euratom Thermische Wärmepumpe
JPS60149521A (ja) * 1984-01-18 1985-08-07 Eisai Co Ltd 高眼圧・緑内障治療・予防用点眼剤
US5573758A (en) * 1995-04-28 1996-11-12 Allergan Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
US5925342A (en) * 1996-11-13 1999-07-20 Allergan Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
GB9720797D0 (en) * 1997-09-30 1997-12-03 Rhodes John Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome
ES2142773B1 (es) * 1998-10-07 2001-01-01 Lacer Sa Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia desminuida.
WO2002060449A2 (de) * 2001-01-31 2002-08-08 Merck Patent Gmbh Pharmazeutische formulierung enthaltend pyrazolo[4,3-d]pyrimidine und nitrate oder thienopyrimidine und nitrate
DE60326226D1 (de) * 2002-03-21 2009-04-02 Cayman Chemical Co Prostaglandin f2 alpha analoga in kombination mit einem antimikrobiellen mittel zur behandlung von glaukom
CN1863905A (zh) * 2003-09-08 2006-11-15 得克萨斯系统大学董事会 通过用前列腺素或前列腺素类似物补充培养基加强体外胚发育的方法以及组合物
ES2258365B1 (es) * 2003-10-03 2007-12-01 Lacer, S.A. Derivados de disulfuro, sulfuro, sulfoxido y sulfona de azucares ciclicos y sus usos.

Also Published As

Publication number Publication date
EP2114398A1 (en) 2009-11-11
EP2124930B1 (en) 2010-10-13
CA2674144A1 (en) 2008-07-10
US20080161389A1 (en) 2008-07-03
EP2114398B1 (en) 2010-06-30
ZA200903566B (en) 2010-08-25
ZA200903567B (en) 2010-08-25
CN101600426B (zh) 2012-07-25
JP2010514734A (ja) 2010-05-06
ATE484279T1 (de) 2010-10-15
CN101600426A (zh) 2009-12-09
BRPI0720664A2 (pt) 2014-01-14
CL2007003836A1 (es) 2008-07-11
PL2114398T3 (pl) 2010-11-30
ES2324130A1 (es) 2009-07-30
IL198941A0 (en) 2010-02-17
MX2009007038A (es) 2009-08-25
AU2007341289B2 (en) 2010-08-26
WO2008080955A1 (en) 2008-07-10
EP1941876A1 (en) 2008-07-09
ES2348314T3 (es) 2010-12-02
NO20092764L (no) 2009-07-27
DE602007009877D1 (de) 2010-11-25
CA2674550A1 (en) 2008-07-10
KR20100100584A (ko) 2010-09-15
AR064543A1 (es) 2009-04-08
AU2007341289A1 (en) 2008-07-10
JP2010514733A (ja) 2010-05-06
AU2007341218B2 (en) 2010-09-09
IL198912A0 (en) 2010-02-17
CL2007003837A1 (es) 2008-07-11
CN101600425A (zh) 2009-12-09
RU2009128968A (ru) 2011-02-10
BRPI0720663A2 (pt) 2014-01-14
WO2008080939A1 (en) 2008-07-10
ES2354317T3 (es) 2011-03-14
ATE472324T1 (de) 2010-07-15
KR20090112673A (ko) 2009-10-28
EP2124930A1 (en) 2009-12-02
RU2009128970A (ru) 2011-02-10
UY30847A1 (es) 2008-05-31
PL2124930T3 (pl) 2011-04-29
ES2324130B1 (es) 2010-03-22
DE602007007523D1 (de) 2010-08-12
AU2007341218A1 (en) 2008-07-10
MX2009007040A (es) 2009-08-25

Similar Documents

Publication Publication Date Title
NO20092763L (no) Isosorbid mononitrat derivater for behandling av tarmlidelser
NO20081878L (no) Diacylindazolderivater som lipase- og fosfolipaseinhibitorer
AR047928A1 (es) Derivados de tetrahidropiridoindol
ATE410424T1 (de) Spirocyclische cyclohexan-derivate
NO20084256L (no) DPP IV inhibitorformuleringer
GT200600260A (es) Derivados de benzamida y usos relacionados con los mismos
NO20080284L (no) Cannabionoid aktiv farmasoytisk ingrediens for forbedrede doseringsformer
BRPI0507198A (pt) derivados de bisariluréia
NO20075660L (no) Blanding for behandling av inflammatoriske sykdommer
NO20081844L (no) Terapeutiske forbindelser
NO20092476L (no) Antibakterielle polycykliske ureaforbindelser
NO20084049L (no) Forbindelser med forsterket ampa receptor og anvendelse derav i medisin
UY31314A1 (es) Amidas heterociclicas y sus métodos de uso-976
CY1120435T1 (el) Φαρμακοτεχνικες μορφες που περιλαμβανουν κρυσταλλικες μορφες του μονοενυδρου υδροχλωρικου (r)-7-χλωρο-ν-(κινουκλιδινο-3-υλο) βενζο(β)θειοφαινο-2-καρβοξαμιδιου
DK1771155T3 (da) Fremgangsmåde og sammensætning til behandling af rhinitis
UA92000C2 (en) 1-benzylindole-2-carboxamide derivatives
BRPI0514735A (pt) derivados de piridino sulfonamida como moduladores do receptor de quimiocina
BRPI0607198A2 (pt) composição, uso da composição método de tratamento doenças, e, embalagem farmacêutica
NO20092535L (no) Fumaratsalt av (alfa S, beta R)-6-brom-alfa-[2-(dimetylamino)etyl]-2-metoksy-alfa-1-naftalenyl-beta-fenyl-3-kinolinetanol
NO20061236L (no) Farmasoytiske sammensetninger og fremgangsmater omfattende kombinasjoner av 2-alkyliden-19-nor-vitamin D derivater og paratyroidhoziiton
NO20080220L (no) Formuleringer med hoy medikament belastning og doseringsformer
ECSP088745A (es) Derivados sustituidos de cromanol y su uso
NO20083905L (no) Nye pyron-indol derivater og fremgangsmate for deres fremstilling
AR071120A1 (es) Derivados de diosmetina, su procedimiento de preparacion, las composiciones farmaceuticas que los contienen y su uso en el tratamiento de las enfermedades venosas cronicas.
NO20074933L (no) Farmasoytisk sammensetning som innbefatter et indolylmaleimidderivat

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application